The global drug testing market size was estimated at USD 7.09 billion in 2025 and is projected to reach USD 11.55 billion by 2033, growing at a CAGR of 6.32% from 2026 to 2033. The rising prevalence of substance abuse worldwide has increased the demand for testing solutions.... Read More »
April 2026The global rapid tests market size was estimated at USD 12.76 billion in 2025 and is projected to reach USD 19.30 billion by 2033, growing at a CAGR of 5.31% from 2026 to 2033. The growth can be attributed to the growing geriatric population, rising target disease burden, and increasing ... Read More »
April 2026The global activated clotting time testing market size was estimated at USD 1.19 billion in 2025 and is projected to reach USD 2.13 billion by 2033, growing at a CAGR of 7.6% from 2026 to 2033. The growth of the market is driven by the increasing cardiovascular disease prevalence, growin... Read More »
March 2026The global microsampling & minimally invasive blood collection market size was estimated at USD 2.16 billion in 2025 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 8.15% from 2026 to 2033. The growth is driven by the increasing global burden of chronic condi... Read More »
March 2026The global colorectal cancer diagnostics market size was estimated at USD 9.53 billion in 2025 and is projected to reach USD 14.39 billion by 2033, growing at a CAGR of 5.34% from 2026 to 2033. The industry is driven by the increasing incidence of colorectal cancer, rising demand for ear... Read More »
March 2026The global syphilis testing market size was estimated at USD 1.57 billion in 2025 and is projected to reach USD 2.32 billion by 2033, growing at a CAGR of 5.23% from 2026 to 2033. Key market drivers for dual HIV/syphilis rapid diagnostics include the rising global burden of congenital sy... Read More »
March 2026The global blood collection market size was estimated at USD 5.02 billion in 2025 and is projected to reach USD 8.18 billion by 2033, growing at a CAGR of 6.33% from 2026 to 2033. The market growth is attributed to an increase in the number of diagnostic procedures involving blood sample... Read More »
March 2026The global blood-based biomarker for Alzheimer’s disease diagnostics market size was estimated at USD 169.22 million in 2025 and is projected to reach USD 529.90 million by 2033, growing at a CAGR of 17.37% from 2026 to 2033. A pivotal catalyst was the U.S. FDA’s May 16, 2025... Read More »
March 2026The global pyrogen and endotoxin testing market size was estimated at USD 2.56 billion in 2025 and is projected to reach USD 4.46 billion by 2033, growing at CAGR of 7.22% from 2026 to 2033. The increasing demand for pyrogen and endotoxin testing products in the pharmaceutical and biotec... Read More »
March 2026The global blood preparation market size was estimated at USD 53.56 billion in 2025 and is anticipated to reach USD 91.88 billion by 2033, growing at a CAGR of 7.1% from 2026 to 2033. The growing incidence of blood-related disorders, the rising number of transfusion procedures, and the i... Read More »
March 2026The global vitamin D toxicity market size was estimated at USD 170.58 million in 2025 and is expected to reach by USD 461.83 million by 2033, growing at a CAGR of 13.31% from 2026 to 2033. The increasing use of high-dose vitamin D supplements, rising awareness of vitamin D deficiency, an... Read More »
March 2026The global self-testing market size was estimated at 11.78 billion in 2025 and is expected to reach USD 21.92 billion by 2033, growing at a CAGR of 8.46% from 2026 to 2033. This growth is driven by increasing emphasis on personalized healthcare, technological advancements in rapid diagno... Read More »
March 2026The global bilirubin testing market size was estimated at USD 2.16 billion in 2025 and is projected to reach USD 2.94 billion by 2033, growing at a CAGR of 4.04% from 2026 to 2033. The market is experiencing a transformative phase, driven by an urgent need for early diagnostic tools in n... Read More »
March 2026The global kidney function tests market size was valued at USD 1.12 billion in 2025 and is projected to reach USD 1.77 billion by 2033, growing at a CAGR of 5.87% from 2026 to 2033. Several factors are anticipated to drive market growth, including increased investments by industry player... Read More »
February 2026The global cardiac biomarkers market size was estimated at USD 20.81 billion in 2025 and is expected to reach USD 49.31 billion by 2033, growing at a CAGR of 11.5% from 2026 to 2033. The market is driven by the rising prevalence of cardiovascular diseases such as acute coronary syndrome,... Read More »
February 2026The global qPCR instruments market size was estimated at USD 1.19 billion in 2025 and is expected to reach USD 2.02 billion by 2033, growing at a CAGR of 7.0% from 2026 to 2033. The rising adoption of molecular diagnostics for infectious disease detection, increasing demand for rapid and... Read More »
February 2026The global at-home STI testing market size was estimated at USD 2.98 billion in 2025 and is projected to reach USD 5.86 billion by 2033, growing at a CAGR of 8.85% from 2026 to 2033. The rising prevalence of sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, a... Read More »
February 2026The France in vitro diagnostics market size was estimated at USD 4.37 billion in 2025 and is projected to reach USD 6.93 billion by 2030, growing at a CAGR of 5.86% from 2026 to 2033. Some of the key growth factors driving the market growth include the increasing prevalence of chronic an... Read More »
February 2026The global in vitro diagnostics market size was estimated at USD 106.29 billion in 2025 and is projected to reach USD 128.18 billion by 2033, growing at a CAGR of 2.40% from 2026 to 2033. This market growth is attributed to the rising global demand for accurate, rapid, and personalized d... Read More »
February 2026The U.S. latent tuberculosis infection detection market size was estimated at USD 427.61 million in 2025 and is projected to reach USD 651.11 million by 2033, growing at a CAGR of 5.17% from 2026 to 2033. This growth is driven by an increasing risk of developing active tuberculosis infection from latent tuberculosis... Read More »
February 2026